Added to YB: 2026-07-01
Pitch date: 2026-06-29
HIMS [bullish]
Hims & Hers Health, Inc.
+5.86%
current return
Author Info
No bio for this author
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$7.9B
Pitch Price
$32.75
Price Target
70.00 (+110%)
Dividend
N/A
EV/EBITDA
81.86
P/E
-580.98
EV/Sales
3.48
Sector
Health Care Providers and Services
Category
growth
Long-term Portfolio: Hims & Hers Thesis.
HIMS: Bull thesis as 'Netflix of healthcare' platform deleting friction across telehealth. ~82% 3-mo retention, data moat via Labs AI (130+ biomarkers), MedMatch, Trybe Labs. Novo went from suing to selling Wegovy via Hims. Stock volatile ($14-70, now mid-$30s). Long-term founder-vision bet.
Read full article (8 min)